BMO Capital Positive on Abbvie (ABBV) Humira Win Versus Amgen (AMGN)
Go back to BMO Capital Positive on Abbvie (ABBV) Humira Win Versus Amgen (AMGN)| AbbVie (NYSE: ABBV) | Delayed: 261.83 -4.14 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $265.97 | 52 Week High | $68.12 | |||
| Open | $265.69 | 52 Week Low | $50.71 | |||
| Day High | $265.93 | P/E | 56.80 | |||
| Day Low | $260.48 | EPS | $4.61 | |||
| Volume | 5,228,796 | |||||
| Amgen Inc (NASDAQ: AMGN) | Delayed: 433.73 -8.63 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $442.36 | 52 Week High | $176.85 | |||
| Open | $435.78 | 52 Week Low | $133.64 | |||
| Day High | $441.34 | P/E | 65.32 | |||
| Day Low | $431.07 | EPS | $6.64 | |||
| Volume | 2,914,113 | |||||

